Grok Bot vs Hermes vs OpenMausBot: which AI teammate stack for a healthcare agency

Grok Bot, Hermes, and OpenMausBot all look like a roster of always-on AI teammates. For a healthcare marketing agency, the useful comparison is not the sidebar. It is where each product draws the security boundary: Grok Bot at the shared cloud account, Hermes at the self-hosted profile on a shared machine, and OpenMausBot as a local-first open roster you operate yourself. Use any of them for non-PHI ops only unless you have a HIPAA-aware architecture, and bring in a build partner like BKLYN when the work must sit near regulated client systems.

That is the short map. The rest of this piece is for agency leads who sell to pharma, biotech, wellness, and health brands, and who outsource engineering when the work gets real. It sits next to our sibling guide on Grok bots for healthcare agencies. Educational first. Soft guidance on when BKLYN is the right build partner comes later. This is guidance for operators, not legal advice.

The interface converged. The security boundary did not.

Create a few named agents, assign jobs, and let them hand work around. That surface now shows up in managed cloud products and in open-source projects. A sidebar labeled Research, Ops, and Draft sounds like separate seats. Public architecture coverage says otherwise.

The New Stack mapped how these teammate products draw different lines: Grok Bot around the user account, Hermes around the profile on a shared host, and other projects around sandboxes or containers. OpenMausBot sits in the same conversation as a local-first, open-source take on the roster shape. The interface converged. The security answer did not.

For a healthcare marketing agency, that gap matters more than polish scores. If one bot can reach another bot's files, sessions, or credentials, a named roster is not isolation. It is a shared work surface with labels.

Snapshot comparison

Use this table as a first pass. For deeper architecture notes on account vs profile boundaries, read The New Stack's boundary map.

None of these three is a HIPAA product by default. Do not invent BAAs, PHI-safe claims, or compliance status from a demo.

Grok Bot in plain English

Grok Bot is a managed cloud teammate product. You get a roster of named bots that can open tools, work through tasks, and come back for approval. The computer is vendor-run, which is why work can continue after you close your laptop.

Public documentation is clear on the boundary. Named bots share one account-level machine. Browser sessions, cookies, files, and many credentials are shared across the roster. Separate screens let bots run browser and desktop tools in parallel. Those screens are work surfaces, not security boundaries. If another bot on the account should not see a credential or file, keep it off that machine.

Approval gates for sensitive actions exist. Treat classifier approvals as product UX, not a hard security boundary. Public guidance cited in The New Stack makes that distinction explicit.

Best fit: non-PHI research and ops under one trusted operator account, when overnight continuity matters more than per-bot filesystem separation.

Hermes in plain English

Hermes, from Nous Research, is open-source and self-hosted. A bot is a profile. Each profile can carry its own configuration, memory, skills, credentials, and chat history on disk. Bot Mode turns those profiles into a roster that can hand work to named teammates.

That design is meaningfully stronger than a shared cloud account for workstation-level state separation. It is still not multi-tenant isolation. Profiles share the host OS user and filesystem permissions. What ends up in a new profile depends on how you create it and what you edit afterward. You own security, updates, logging, and uptime.

Model freedom is a real advantage: OpenRouter, local models, Nous Portal, and similar paths. Agencies get more control and more responsibility. If nobody on the team can run a self-hosted agent stack, Hermes is not free. It is an ops commitment.

Best fit: non-PHI agency work where different bots should keep different local state, and someone will own the machine.

OpenMausBot in plain English

OpenMausBot is an open-source, local-first take on the Grok Bot-style chat roster. You bring your own Claude, Codex, Grok-style CLIs, and subscriptions. The pitch is ownership and cost control, not teammate-coordination polish.

Treat it as early open-source software with a public repo. Products in this lane often win on transparency and price, then lag on handoffs, always-on cloud continuity, and polished approval flows. Fine for internal experiments. A weak reason to connect a client production system.

Best fit: early non-PHI pilots where the agency wants to learn the roster pattern without a managed cloud seat, and will operate the stack itself.

The line a healthcare agency cannot cross casually

Here is the blunt line: do not casually put any of these three products on regulated client data.

PHI, BAAs, audit logs, least privilege, and retention rules are not marketing preferences. If an agent can read, write, or move information that identifies a patient (or that your client treats as regulated), you need a deliberate architecture and clear ownership of contracts and access.

Important constraint for client conversations: do not invent HIPAA status for Grok Bot, Hermes, or OpenMausBot. A useful product is not a HIPAA product. A healthcare logo in a demo is not a BAA. Confirm vendor posture with counsel and with the vendor's own documentation before anyone claims compliance in a meeting.

BKLYN's guidance here is operational, not legal advice. If you are unsure whether a dataset or system is in scope, treat it as sensitive until legal says otherwise.

Safe lane for agency teams this quarter

Start where the upside is real and the blast radius is small: non-PHI agency ops and research. The same safe lane from our Grok bots primer still applies, regardless of which roster product you try.

Safe-lane examples that fit most healthcare marketing shops:

• Public and permitted competitive research, landscape mapping, and briefing packs for human strategists
• First-pass outlines and structure maps that humans rewrite into primary client copy
• Project ops: status digests, checklist hygiene, meeting notes into trackers (non-sensitive fields only)
• Internal knowledge already cleared for tools your company owns
• Asset inventories and production queues that do not include patient or customer health data

Frame AI as research and mapping support. Humans still write primary client copy, especially anything that will face medical, legal, or regulatory review. Keep a named human in the approval loop for anything that leaves the building.

Pick the product from the table above based on hosting and threat model, not on which demo looked smoothest.

When to bring in a shop like BKLYN

Bring in a software partner when the ask stops being "which roster should we try" and starts being "build something durable that can live near regulated systems."

That usually looks like one of these:

• A custom agent or automation that must sit behind your client's access model, logging, and review gates
• A productized bot or workflow for a healthtech client, not just an internal agency experiment
• Grant or SBIR-path work where the engineering has to survive diligence (BKLYN has taken an idea through an SBIR-funded healthtech build into Level 2 territory; client anonymized here)
• Agency-partner engineering alongside brands in the Pfizer / Genentech / BMS class of expectation, where process maturity matters as much as clever prompts
• A stack that needs HIPAA-aware architecture, not a personal login to a consumer or early open-source teammate product

BKLYN is a software partner (est. 2012) that builds product, AI and automation, and fractional technical leadership for teams that outsource engineering rather than standing up a full internal department overnight. On regulated work, BKLYN is HIPAA certified for the builds it takes on. The useful promise to agencies is simpler: when agents need real engineering, auditability, and a partner who already works in healthcare-adjacent environments, outsourcing the build is often safer than bolting a roster demo onto a brand account.

If that is the conversation you are having with a client, email hello@bklyn.co.

A practical decision checklist

Use this before anyone buys seats or connects production tools:

1. Threat model first. Name what one bot must never reach if another bot goes wrong. Account boundary, profile boundary, and host boundary are different answers.
2. Where credentials live. Write down every login, API, Drive, Slack, CRM, or CMS the roster can touch. Keep client production credentials off shared agent machines.
3. Laptop-closed need. If work must continue overnight without your host online, managed cloud is the fit. If not, self-hosted or local-first may be enough.
4. Who owns ops. Self-hosted and local-first products shift security, updates, and uptime onto your team (or your build partner).
5. Non-PHI pilot only. Name the datasets and systems the bots may touch. If PHI might appear, stop and redesign.
6. BAA and contract owner. Assign a human who owns vendor review with legal whenever a client system is involved. Do not assume any of these three products is covered.
7. Success metrics. Measure leads, quotes, orders, cycle time, or error rates. Do not measure "AI mentions."

FAQ

Can we put any of these on a pharma brand account tomorrow?

Usually no, not if "on the account" means production credentials, promotional systems, or anything that could include regulated data. You can often start tomorrow on a non-PHI sandbox: research, outlines, and internal ops with clear approval gates. Brand-account access waits on legal, IT, and a deliberate architecture.

Is a named bot the same as isolation?

No. A named bot is a label and a workflow. Isolation is an architecture claim. On Grok Bot, public docs put the boundary at the shared account. On Hermes, the boundary is stronger at the profile level, but profiles still share the host. On OpenMausBot, you operate a local roster yourself. Read the security page before the launch page.

Claude Code / Cursor vs these teammate products?

Claude Code, Cursor, and similar coding agents help a human drive development work. Grok Bot, Hermes, and OpenMausBot are closer to a roster of persistent teammates with tools and handoffs. Same broader shift toward durable agents, different day-to-day jobs. Neither category removes the PHI line. Pick the stack you can govern.

What does BKLYN actually build here?

Custom software, agent and automation architecture, product builds, and fractional technical leadership when an agency or healthtech team needs engineering they do not want to staff full-time. Typical asks include safe internal automations, client-facing product work, and HIPAA-aware systems with human approval loops. Start the conversation at bklyn.co or hello@bklyn.co.